CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235,278,049 | -12.8% | 7,986,356 | -3.4% | 0.05% | -7.8% |
| Q2 2023 | $269,793,464 | +1.9% | 8,270,799 | +9.9% | 0.05% | -1.9% |
| Q1 2023 | $264,861,652 | -11.7% | 7,526,617 | +15.0% | 0.05% | -13.3% |
| Q4 2022 | $299,787,613 | +27.9% | 6,542,724 | +35.3% | 0.06% | +20.0% |
| Q3 2022 | $234,327,000 | +54.2% | 4,836,480 | +25.0% | 0.05% | +61.3% |
| Q2 2022 | $151,998,000 | +207.1% | 3,868,632 | +187.7% | 0.03% | +287.5% |
| Q1 2022 | $49,491,000 | -3.3% | 1,344,493 | +19.7% | 0.01% | 0.0% |
| Q4 2021 | $51,190,000 | +36.2% | 1,123,072 | +6.8% | 0.01% | +33.3% |
| Q3 2021 | $37,593,000 | +57.1% | 1,051,856 | -13.0% | 0.01% | +50.0% |
| Q2 2021 | $23,933,000 | +3.3% | 1,209,322 | +21.4% | 0.00% | 0.0% |
| Q1 2021 | $23,173,000 | -5.2% | 996,277 | -15.3% | 0.00% | -20.0% |
| Q4 2020 | $24,455,000 | -61.6% | 1,176,795 | -60.0% | 0.01% | -61.5% |
| Q3 2020 | $63,663,000 | -10.3% | 2,940,539 | -2.4% | 0.01% | -18.8% |
| Q2 2020 | $70,985,000 | +1359.7% | 3,011,620 | +291.3% | 0.02% | +1500.0% |
| Q4 2018 | $4,863,000 | -72.2% | 769,637 | -56.6% | 0.00% | -75.0% |
| Q3 2018 | $17,471,000 | +15.9% | 1,773,650 | -2.3% | 0.00% | +33.3% |
| Q2 2018 | $15,068,000 | +3.6% | 1,815,429 | -10.1% | 0.00% | 0.0% |
| Q1 2018 | $14,546,000 | -17.5% | 2,020,256 | -6.6% | 0.00% | -25.0% |
| Q4 2017 | $17,632,000 | -47.6% | 2,163,318 | -6.8% | 0.00% | -50.0% |
| Q3 2017 | $33,651,000 | +5.5% | 2,320,797 | -12.0% | 0.01% | 0.0% |
| Q2 2017 | $31,893,000 | +83.9% | 2,635,786 | +95.2% | 0.01% | +100.0% |
| Q1 2017 | $17,347,000 | +2.2% | 1,350,009 | -3.3% | 0.00% | 0.0% |
| Q4 2016 | $16,967,000 | +15.1% | 1,396,523 | -13.0% | 0.00% | 0.0% |
| Q3 2016 | $14,744,000 | -14.0% | 1,606,040 | -11.1% | 0.00% | 0.0% |
| Q2 2016 | $17,152,000 | +26.1% | 1,807,381 | -6.3% | 0.00% | 0.0% |
| Q1 2016 | $13,597,000 | +406.4% | 1,928,693 | +651.4% | 0.00% | +300.0% |
| Q4 2015 | $2,685,000 | +22.3% | 256,665 | -6.3% | 0.00% | 0.0% |
| Q4 2014 | $2,195,000 | +105.5% | 274,039 | -9.7% | 0.00% | – |
| Q3 2014 | $1,068,000 | -69.3% | 303,419 | -58.3% | 0.00% | -100.0% |
| Q2 2014 | $3,482,000 | -43.2% | 728,472 | +12.8% | 0.00% | -50.0% |
| Q1 2014 | $6,135,000 | +32.1% | 645,832 | -9.6% | 0.00% | +100.0% |
| Q4 2013 | $4,644,000 | -7.5% | 714,537 | +8.0% | 0.00% | -50.0% |
| Q3 2013 | $5,023,000 | – | 661,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |